608 related articles for article (PubMed ID: 25582744)
1. Patterns of Recurrence in Patients with Stage IIIB/C Cutaneous Melanoma of the Head and Neck Following Surgery With and Without Adjuvant Radiation Therapy: Is Isolated Regional Recurrence Salvageable?
Barbour S; Mark Smithers B; Allan C; Bayley G; Thomas J; Foote M; Burmeister B; Barbour AP
Ann Surg Oncol; 2015 Nov; 22(12):4052-9. PubMed ID: 25582744
[TBL] [Abstract][Full Text] [Related]
2. Regional control of head and neck melanoma with selective neck dissection.
Geltzeiler M; Monroe M; Givi B; Vetto J; Andersen P; Gross N
JAMA Otolaryngol Head Neck Surg; 2014 Nov; 140(11):1014-8. PubMed ID: 25275362
[TBL] [Abstract][Full Text] [Related]
3. Elective, therapeutic, and delayed lymph node dissection for malignant melanoma of the head and neck: analysis of 1444 patients from 1970 to 1998.
Fisher SR
Laryngoscope; 2002 Jan; 112(1):99-110. PubMed ID: 11802046
[TBL] [Abstract][Full Text] [Related]
4. Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy.
Lee RJ; Gibbs JF; Proulx GM; Kollmorgen DR; Jia C; Kraybill WG
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):467-74. PubMed ID: 10661355
[TBL] [Abstract][Full Text] [Related]
5. Regional control of melanoma neck node metastasis after selective neck dissection with or without adjuvant radiotherapy.
Hamming-Vrieze O; Balm AJ; Heemsbergen WD; Hooft van Huysduynen T; Rasch CR
Arch Otolaryngol Head Neck Surg; 2009 Aug; 135(8):795-800. PubMed ID: 19687401
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.
Burmeister BH; Henderson MA; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
Lancet Oncol; 2012 Jun; 13(6):589-97. PubMed ID: 22575589
[TBL] [Abstract][Full Text] [Related]
7. The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma.
Agrawal S; Kane JM; Guadagnolo BA; Kraybill WG; Ballo MT
Cancer; 2009 Dec; 115(24):5836-44. PubMed ID: 19701906
[TBL] [Abstract][Full Text] [Related]
8. Stage III melanoma in the axilla: patterns of regional recurrence after surgery with and without adjuvant radiation therapy.
Pinkham MB; Foote MC; Burmeister E; Thomas J; Meakin J; Smithers BM; Burmeister BH
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):702-8. PubMed ID: 23773393
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for nodal recurrence after lymphadenectomy for melanoma.
Pidhorecky I; Lee RJ; Proulx G; Kollmorgen DR; Jia C; Driscoll DL; Kraybill WG; Gibbs JF
Ann Surg Oncol; 2001 Mar; 8(2):109-15. PubMed ID: 11258774
[TBL] [Abstract][Full Text] [Related]
10. Surgery and adjuvant radiotherapy for cutaneous melanoma considered high-risk for local-regional recurrence.
Mendenhall WM; Shaw C; Amdur RJ; Kirwan J; Morris CG; Werning JW
Am J Otolaryngol; 2013; 34(4):320-2. PubMed ID: 23375588
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant postoperative radiotherapy to the cervical lymph nodes in cutaneous melanoma: is there any benefit for high-risk patients?
Moncrieff MD; Martin R; O'Brien CJ; Shannon KF; Clark JR; Gao K; McCarthy WM; Thompson JF
Ann Surg Oncol; 2008 Nov; 15(11):3022-7. PubMed ID: 18958539
[TBL] [Abstract][Full Text] [Related]
12. The management of cervical lymph nodes in patients with cutaneous melanoma.
Martin RC; Shannon KF; Quinn MJ; Saw RP; Spillane AJ; Stretch JR; Colman MH; Gao K; Thompson JF
Ann Surg Oncol; 2012 Nov; 19(12):3926-32. PubMed ID: 22669449
[TBL] [Abstract][Full Text] [Related]
13. A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma.
Ballo MT; Zagars GK; Gershenwald JE; Lee JE; Mansfield PF; Kim KB; Camacho LH; Hwu P; Ross MI
Ann Surg Oncol; 2004 Dec; 11(12):1079-84. PubMed ID: 15576833
[TBL] [Abstract][Full Text] [Related]
14. Role of postoperative irradiation for patients with bilateral cervical nodal metastases from cutaneous melanoma: a critical assessment.
Guadagnolo BA; Myers JN; Zagars GK
Head Neck; 2010 Jun; 32(6):708-13. PubMed ID: 19787786
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of selective neck dissection for nodal metastasis with involvement of nonlymphatic structures.
Dhiwakar M; Robbins KT; Rao K; Vieira F; Malone J
Head Neck; 2011 Aug; 33(8):1099-105. PubMed ID: 21755555
[TBL] [Abstract][Full Text] [Related]
16. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
[TBL] [Abstract][Full Text] [Related]
17. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck.
Moore BA; Weber RS; Prieto V; El-Naggar A; Holsinger FC; Zhou X; Lee JJ; Lippman S; Clayman GL
Laryngoscope; 2005 Sep; 115(9):1561-7. PubMed ID: 16148695
[TBL] [Abstract][Full Text] [Related]
18. BRAF mutation status is an independent prognostic factor for resected stage IIIB and IIIC melanoma: implications for melanoma staging and adjuvant therapy.
Barbour AP; Tang YH; Armour N; Dutton-Regester K; Krause L; Loffler KA; Lambie D; Burmeister B; Thomas J; Smithers BM; Hayward NK
Eur J Cancer; 2014 Oct; 50(15):2668-76. PubMed ID: 25070294
[TBL] [Abstract][Full Text] [Related]
19. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
20. Incidence and location of positive nonsentinel lymph nodes in head and neck melanoma.
Gyorki DE; Boyle JO; Ganly I; Morris L; Shaha AR; Singh B; Wong RJ; Shah JP; Busam K; Kraus D; Coit DG; Patel S
Eur J Surg Oncol; 2014 Mar; 40(3):305-10. PubMed ID: 24361245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]